Veru Inc. (VERU)
NASDAQ: VERU · Real-Time Price · USD
2.290
-0.050 (-2.14%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Veru Inc. Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
20
Market Cap
36.76M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Atara Biotherapeutics | 120.77M |
| Cue Biopharma | 27.47M |
| Evaxion | 7.53M |
| CervoMed | 4.01M |
| Aligos Therapeutics | 2.19M |
| Pluri | 1.34M |
| Werewolf Therapeutics | 1.14M |
| RenovoRx | 1.12M |
VERU News
- 7 weeks ago - Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss - GlobeNewsWire
- 2 months ago - Veru Inc. Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference - Transcripts
- 2 months ago - Veru Inc. Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - Veru to Report Fiscal 2026 First Quarter Financial Results on February 11th - GlobeNewsWire
- 4 months ago - Veru Inc. Earnings Call Transcript: Q4 2025 - Transcripts
- 4 months ago - Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress - GlobeNewsWire
- 4 months ago - Veru to Report Fiscal Year 2025 Financial Results on December 17th - GlobeNewsWire
- 6 months ago - Veru to Present Two Abstracts at ObesityWeek 2025 - GlobeNewsWire